SGMO - Sangamo Therapeutics 10% Owner Sold $3.00M In Company Stock | Benzinga
BIOGEN INC, 10% Owner at Sangamo Therapeutics (NASDAQ:SGMO), reported a large insider sell on September 28, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that INC sold 6,000,000 shares of Sangamo Therapeutics. The total transaction amounted to $3,000,000.
Sangamo Therapeutics shares are trading up 3.93% at $0.6 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, however, ...